HIGHLIGHTS
- who: August and colleagues from the Jiaotong, China have published the article: Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme, in the Journal: (JOURNAL)
- what: The aim of this paper was to analyze the active components, potential key targets and biological pathways of XLD. This study provides useful information to understand the biological process of XLD in GBM and offers new therapeutic options for the treatment of GBM. The authors systematically explored the potential molecular mechanism of XLD in the brain by performing GO and KEGG pathway enrichment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.